STEFAN WORGALL, MD, PHD
Medical Practice at 72 St, New York, NY
License number
New York 228460
Category
Medical Practice
Type
Pediatrics
License number
New York 228460
Category
Medical Practice
Type
Pediatric Pulmonology
Address
Address
428 E 72Nd St, New York, NY 10021
Phone
(212) 746-3567
(212) 746-8663 (Fax)
(212) 746-0373
(212) 746-7481 (Fax)
(212) 746-8663 (Fax)
(212) 746-0373
(212) 746-7481 (Fax)
Personal information
See more information about STEFAN WORGALL at radaris.comName
Address
Phone
450 E 63Rd St APT 2E, New York, NY 10065
New York, NY
435 70Th St, New York, NY 10021
450 63Rd St, New York, NY 10001
450 E 63Rd St, New York, NY 10065
Organization information
See more information about STEFAN WORGALL at bizstanding.comStefan Worgall MD,PHD
505 E 70 St, New York, NY 10021
Industry:
Pediatric Pulmonologist, Pediatrician
Phone:
(646) 962-3410 (Phone)
Description:
There are 6 doctors at this site. Surgery is not performed at this site.
Stefan Worgall
Professional information
Dr. Stefan Worgall, New York NY - MD (Doctor of Medicine)
Specialties:
Pediatric Pulmonology
Address:
Pediatric Primary Care
505 E 70Th St SUITE HT553, New York 10021
(212) 746-3303 (Phone)
Weill Cornell Med Cllg Ped Pul
505 E 70 St Suite Ht-3, New York 10021
(646) 962-3410 (Phone)
New York Weill Cornell Ped Pul
505 E 70Th St SUITE 3, New York 10021
(646) 962-3410 (Phone)
505 E 70Th St SUITE HT553, New York 10021
(212) 746-3303 (Phone)
Weill Cornell Med Cllg Ped Pul
505 E 70 St Suite Ht-3, New York 10021
(646) 962-3410 (Phone)
New York Weill Cornell Ped Pul
505 E 70Th St SUITE 3, New York 10021
(646) 962-3410 (Phone)
Certifications:
Pediatric Pulmonology, 2006, Pediatrics, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Pediatric Primary Care
505 E 70Th St SUITE HT553, New York 10021
Weill Cornell Med Cllg Ped Pul
505 E 70 St Suite Ht-3, New York 10021
New York Weill Cornell Ped Pul
505 E 70Th St SUITE 3, New York 10021
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
505 E 70Th St SUITE HT553, New York 10021
Weill Cornell Med Cllg Ped Pul
505 E 70 St Suite Ht-3, New York 10021
New York Weill Cornell Ped Pul
505 E 70Th St SUITE 3, New York 10021
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
Education:
Medical School
Ruprecht-Karls-Universitaet Heidelberg, Medizinische Gesamtfakultat
Ny and Presby Hospital
Ruprecht-Karls-Universitaet Heidelberg, Medizinische Gesamtfakultat
Ny and Presby Hospital
Stefan Worgall, New York NY
Specialties:
Pediatrics, Pediatric Endocrinology, Pediatric Pulmonology, Pulmonary Disease
Work:
Cornell University
428 E 72Nd St, New York, NY 10021 NewYork-Presbyterian / Weill Cornell
525 E 68Th St, New York, NY 10065 NewYork-Presbyterian / Weill Cornell
505 E 70Th St, New York, NY 10021
428 E 72Nd St, New York, NY 10021 NewYork-Presbyterian / Weill Cornell
525 E 68Th St, New York, NY 10065 NewYork-Presbyterian / Weill Cornell
505 E 70Th St, New York, NY 10021
Education:
Ruprecht-Karls-Universitaet Heidelberg (1991)
Vaccines For Prevention And Treatment Of Addiction
US Patent:
2011008, Apr 14, 2011
Filed:
Jun 4, 2009
Appl. No.:
12/995851
Inventors:
Ronald G. Crystal - New York NY, US
Philip L. Leopold - Basking Ridge NJ, US
Stefan Worgall - New York NY, US
Julie L. Boyer - New York NY, US
Philip L. Leopold - Basking Ridge NJ, US
Stefan Worgall - New York NY, US
Julie L. Boyer - New York NY, US
Assignee:
CORNELL UNIVERSITY - Ithaca NY
International Classification:
A61K 39/235, A61K 31/7088, A61P 25/36, A61P 25/30, A61P 25/34, C12N 7/00, C12N 15/63
US Classification:
4241991, 4242331, 514 44 R, 4352351, 4353201
Abstract:
The invention provides an adenovirus-antigen conjugate comprising an adenovirus with a coat protein and an antigen of an addictive drug conjugated to the coat protein of the adenovirus. The invention also provides an adenoviral vector comprising a nucleic acid sequence which encodes an antibody directed against the addictive drug. The invention further provides a method of inducing an immune response against an addictive drug or reducing the effect of an addictive drug in a human by ad-ministering to the human the aforementioned adenovirus-antigen conjugate or antibody encoding adenoviral vector.